Biogen CEO

There does seem to be a little bit of musical chairs in the highest ranks of science in the pharmaceutical industry. Mattai Mamen, who we've spoken about was briefly a candidate for the biogen CEO position, left J&J's top research position. Similarly over at Novartis J. Bradner left the analogous position there. There's just change a foot at the highest levels of some of the largest drug makers specifically in Europe.